AMArjun Mn

Arjun Mn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Arjun Mn has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Serum interleukin-6 in seropositive rheumatoid arthritis and response to tocilizumab: An observational study

    by Abhishek Kumar, D. S. Bhakuni, Sivasami Kartik, Arun Hegde, K. Shanmuganandan, Kavita Singh, Vivek Vasdev, Arjun Mn

    Objective: There is no clinically useful biomarker as a predictor of response to any class of biological disease-modifying antirheumatic drugs (bDMARD). Serum interleukin-6 (IL-6) has a major role in the pathogenesis of rheumatoid arthritis (RA) and its serum level in patients of RA may predict response to treatment with IL-6 receptor (IL-6R) antagonist tocilizumab. Methods: Biological DMARD naïve patients of seropositive RA, fulfilling American College of Rheumatology/European League Against Rheumatism classification criteria 2010, were treated with 06 doses of tocilizumab (8mg/kg) at monthly interval. Baseline and post-treatment serum IL-6 levels were measured and correlated with response to treatment measured by disease activity score-28 joints erythrocyte sedimentation rate (DAS28 ESR) after treatment. Results: The study included 34 patients and 26 (70%) of them achieved DAS-28 remission (DAS28 ESR < 2.6). The baseline serum IL-6 did not correlate with post-treatment DAS28 ESR (R −0.197, P = .264). Though, statistically not significant (P = .085) more patients with comparatively lower baseline serum IL-6 attained DAS28 remission (16 out of 17, P = .085). There was an increase in the serum IL-6 level (median 40.5pg/ml [IQR 130.2] to 72.6pg/ml [IQR 162.5]) after tocilizumab treatment and the change in IL-6 level also did not correlate with post-treatment DAS28 ESR (R −0.240, P = .172). Conclusion: Higher number of patients with comparatively lower serum IL-6 level attained DAS28 remission in this study; however, it was not statistically significant. It requires further evaluation in larger studies to make any conclusion on the role of serum IL-6 as a predictor of response to tocilizumab in seropositive RA. Cite this article as: Kumar A, Bhakuni DS, Kartik S, et al. Serum interleukin-6 in seropositive rheumatoid arthritis and response to tocilizumab: An observational study. Eur J Rheumatol. 2021;9(1):26-30.


  • Open Access

    Predictive Factors of Inadvertent Durotomy in Lumbosacral Prolapsed Intervertebral Disc Surgeries: A Retrospective Review at a Tertiary Care Centre in India

    by Ajay Sebastian Carvalho, Kishan Kumar Yadav, Arjun Mn, Ashok Kumar, Roopa Shivashankar, Vijay Kumar Gupta

    Introduction: Inadvertent dural tear is an undesirable intraoperative complication of spine surgery, with a reported incidence range of 1.7% to 17%. The purpose of this study is to determine the predictive factors of inadvertent durotomies (ID) in lumbosacral prolapsed disc surgeries and suggest a scoring system for pre-operative assessment of these predictors. Methods and Materials: This is a retrospective observational study done in 230 patients operated for prolapsed lumbar intervertebral discs, between January 2010 to November 2012. The inadvertent dural tears were grouped as unrecognised, simple and complicated. Data were collected regarding diagnosis, comorbidities, surgical procedure, operating surgeon, prior spine surgeries, type of ID and complications. Results: Of the 230 patients, ID was seen in 6.5 % (15 patients). Higher incidences were noted in elderly (33.3%) and obese (7.6%). Bone nibbler and Kerrison’s rongeur were the most common tools associated. Redo surgeries have a significant higher incidence (12.9%) as compared to the first surgery (5.53%). Conclusions: The risk of ID in prolapsed lumbar intervertebral disc surgeries is high in presence of bony and ligamentous canal stenosis, instrument handling, and in smaller size of incisions. Additionally, elderly age of patients, obesity and surgeon fatigue appears to be a major determinant. Conscious effort to prevent this complication during surgery by predicting risks pre-operatively using a scoring system can aid in preventing ID.